Evidence map›Paper›PMID 36437828›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2022

Therapeutic and Neuroprotective Effects of Bushen Jianpi Decoction on a Rotenone-Induced Rat Model of Parkinson's Disease.

Wei Liang, Lulu Yao, Jiahao Chen, Zhiying Chen, Xiling Wu, Xiaobo Huang

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wei LiangDepartment of Traditional Chinese Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.ORCID https://orcid.org/0000-0002-8096-8059
Lulu YaoDepartment of Traditional Chinese Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.ORCID https://orcid.org/0000-0002-3329-6157
Jiahao ChenDepartment of Neurobiology, Capital Medical University, Beijing 100069, China.ORCID https://orcid.org/0000-0003-4110-2049
Zhiying ChenDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.ORCID https://orcid.org/0000-0001-6020-4484
Xiling WuDepartment of Traditional Chinese Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.ORCID https://orcid.org/0000-0001-7322-8776
Xiaobo HuangDepartment of Traditional Chinese Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.ORCID https://orcid.org/0000-0001-5740-483X
Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is an age-related neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra (SN) pars compacta. Dopamine (DA) replacement therapy is one of the most effective drug treatments for PD; however, long-term levodopa treatment can lead to various side effects that negatively impact the quality of life of patients. Therefore, finding safe and effective alternative drugs to treat PD is of clinical importance. The Bushen-Jianpi decoction (BSJPD) was derived from classic traditional Chinese medicine and has been shown to be effective in the treatment of PD. This study explored the effects and mechanisms of action of BSJPD in PD. In our study, rats were randomly divided into six groups: the vehicle group, rotenone (ROT) + Saline group, ROT + low-dose BSJPD group, ROT + high-dose BSJPD group, ROT + Madopar group, and ROT + low-dose BSJPD + Madopar group. Treatment was administered to the rats once a day for 28 days, and behavioral tests were assessed. Tyrosine hydroxylase (TH), catechol-O-methyltransferase (COMT), monoamine oxidase B (MAO-B), dopa decarboxylase (DDC), alpha-synuclein (

Identifiers

PMID36437828
PMCPMC9699733
OpenAlexW4309466243

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.